Dominion Energy Inc vs TransMedics Group Inc — how do they compare? Dominion Energy Inc trades at $61.71 (market cap $54.31B), while TransMedics Group Inc trades at $78.41 (market cap $2.74B). The key difference: Dominion Energy Inc is far larger — about 19.8× TransMedics Group Inc's market cap, and Dominion Energy Inc pays a 4.32% dividend while TransMedics Group Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Dominion Energy Inc for 76 Days and TransMedics Group Inc for 24 Days on average.
| D | TMDX | |
|---|---|---|
Market Cap | $54.31B | $2.74B |
Volume | 6,944,775 | 949,331 |
Sector | Utilities | Health |
52-Week High | $71.67 | $150.42 |
52-Week Low | $57.08 | $61.99 |
Typical Hold Time | 76 Days | 24 Days |
Enterprise Value | $108.43B | $3.13B |
Dividend Yield | 4.32% | — |
Signals from Pluang's Aura AI — not financial advice
Dominion Energy (D) trades at $61.69, up 0.25% with a bearish technical signal despite recent earnings beats. The company shows strong fundamental improvement with revenue growing to $16.51B in 2025 and net income margin expanding to 18.16%. Analyst consensus is mixed with 36% buy ratings but a $71.56 price target suggests 16% upside potential. Recent news highlights the pending merger with NextEra Energy and ongoing infrastructure investments.
Dominion Energy presents a compelling value opportunity with reasonable valuation multiples (P/E 21.37, P/S 2.96) and consistent earnings outperformance. However, the stock faces headwinds from high debt levels (debt-to-asset ratio 43.49%) and regulatory uncertainty surrounding the proposed merger. The dividend yield of approximately 4.3% provides income support while investors await merger resolution and continued operational execution.
TransMedics Group (TMDX) trades at $78.17, down 3.58% on the day, with a bearish technical signal and mixed earnings history. The company reported strong 2025 results with $605.49M revenue and $190.29M net income, but 2026 projections show margin compression. Recent news highlights insider buying and leadership changes alongside legal investigations into fiduciary duties, creating a complex sentiment backdrop.
The stock offers growth potential with a consensus price target of $99.75, but faces risks from earnings misses, margin pressure, and ongoing legal scrutiny. Analyst consensus remains bullish with 69% buy ratings, yet investors must weigh robust profitability metrics against execution and regulatory uncertainties.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Latest headlines on both assets
Based in Richmond, Virginia, Dominion Energy is an integrated energy company with over 30 gigawatts of electric generation capacity and more than 90,000 miles of electric transmission and distribution lines. Dominion owns a liquefied natural gas export facility in Maryland and is constructing a 5.2 GW wind farm off the Virginia Beach coast.
Read more on D →TransMedics is a pioneering medical technology company that is disrupting the organ transplant market with its Organ Care System (OCS™). By replacing traditional cold storage with portable warm perfusion, the OCS maintains donor organs in a near-physiologic state, allowing for continuous assessment and optimization. Through its National OCS Program (NOP™), TransMedics provides an end-to-end clinical and logistics solution, including a dedicated aviation fleet, to maximize the utilization of donor organs and improve patient outcomes.
Read more on TMDX →